Amyris bags another $24.7 million in Series C; synthetic biology gets another boost

August 25, 2009 | Analyst Insight

Emeryville, CA synthetic biology company Amyris Biotechnologies raised $24.7 million in the first close of a Series C this week from existing investors including Khosla Ventures, Kleiner Perkins Caufield & Byers,...